Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
345 | 3 | TOXICOLOGY//ATLA-ALTERNATIVES TO LABORATORY ANIMALS//1 HYDROXYPYRENE | 36813 |
3123 | 2 | ATLA-ALTERNATIVES TO LABORATORY ANIMALS//EYE IRRITATION//TOXICOLOGY IN VITRO | 2453 |
36559 | 1 | BIMOLANE//PROBIMANE//BISDIOXOPIPERAZINE COMPOUNDS | 96 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | BIMOLANE | authKW | 1608680 | 7% | 70% | 7 |
2 | PROBIMANE | authKW | 1025943 | 5% | 63% | 5 |
3 | BISDIOXOPIPERAZINE COMPOUNDS | authKW | 437736 | 2% | 67% | 2 |
4 | CATIONIZED POLYACRYLAMIDE | authKW | 437736 | 2% | 67% | 2 |
5 | ADULT CLINICAL TRIALS | authKW | 328303 | 1% | 100% | 1 |
6 | ANGIODYNAMICS | authKW | 328303 | 1% | 100% | 1 |
7 | ANTIBREAST CANCER ACTIVITY | authKW | 328303 | 1% | 100% | 1 |
8 | B16F10 B16F1 | authKW | 328303 | 1% | 100% | 1 |
9 | BLOOD FIBRINOGEN CONCENTRATION | authKW | 328303 | 1% | 100% | 1 |
10 | COLON CANCER IN SITU DIAGNOSIS | authKW | 328303 | 1% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 282 | 29% | 0% | 28 |
2 | Dermatology | 135 | 9% | 0% | 9 |
3 | Pharmacology & Pharmacy | 60 | 17% | 0% | 16 |
4 | Medicine, General & Internal | 56 | 13% | 0% | 12 |
5 | Toxicology | 33 | 6% | 0% | 6 |
6 | Psychology | 14 | 3% | 0% | 3 |
7 | Chemistry, Medicinal | 13 | 4% | 0% | 4 |
8 | Chemistry, Multidisciplinary | 13 | 10% | 0% | 10 |
9 | Multidisciplinary Sciences | 11 | 2% | 0% | 2 |
10 | Physiology | 8 | 4% | 0% | 4 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HADASSAH MT | 328303 | 1% | 100% | 1 |
2 | SURG ONCOL SURG C | 328303 | 1% | 100% | 1 |
3 | HAEMOSTASIS THROMBOSIS VASC BIOL | 164150 | 1% | 50% | 1 |
4 | CHEMOPREVENT GRP | 109433 | 1% | 33% | 1 |
5 | IMPERIAL CANC FUND MED ONCOL UNIT | 41036 | 1% | 13% | 1 |
6 | HLTH RISK ASSESSMENT | 32828 | 1% | 10% | 1 |
7 | PERINATAL PATHOL UNIT | 32828 | 1% | 10% | 1 |
8 | SECT CANC | 12157 | 1% | 4% | 1 |
9 | TC | 8871 | 1% | 3% | 1 |
10 | UAB COMPREHENS CANC | 4756 | 1% | 1% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PHYSIOLOGICAL PSYCHOLOGY | 8388 | 3% | 1% | 3 |
2 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 4451 | 4% | 0% | 4 |
3 | ACTA PHARMACOLOGICA SINICA | 3677 | 8% | 0% | 8 |
4 | CANCER CLINICAL TRIALS | 2563 | 1% | 1% | 1 |
5 | CLINICAL & EXPERIMENTAL METASTASIS | 1455 | 3% | 0% | 3 |
6 | ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA | 1313 | 4% | 0% | 4 |
7 | JOURNAL OF THE ROYAL SOCIETY OF MEDICINE | 988 | 4% | 0% | 4 |
8 | NATIONAL ACADEMY SCIENCE LETTERS-INDIA | 786 | 2% | 0% | 2 |
9 | BRITISH JOURNAL OF DERMATOLOGY | 729 | 5% | 0% | 5 |
10 | BRITISH JOURNAL OF HOSPITAL MEDICINE | 721 | 3% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |